Investigación en Neuroprotección de la Retina y Biomarcadores Moleculares en Superficie Ocular en Glaucoma - GIC 21/017
Hospital Ramón y Cajal
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Ramón y Cajal (8)
2021
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
2020
-
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829
2019
-
Changes in Corneal Expression of MUC5AC after Autologous Serum Eyedrop Treatment in Patients with Limbal Stem Cell Deficiency
Current Eye Research, Vol. 44, Núm. 9, pp. 934-940
2016
-
Effects of autologous serum eye drops on conjunctival expression of muc5ac in patients with ocular surface disorders
Cornea, Vol. 35, Núm. 3, pp. 336-341
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
2012
-
Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium
Ophthalmology, Vol. 119, Núm. 5, pp. 923-929